LY2603618,
Rabusertib,
LY2603618,
911222-45-2,
LY 2603618,
LY-2603618,
UNII-3S9L1NU6U7,
IC-83,
3S9L1NU6U7,
(S)-1-(5-bromo-4-methyl-2-(morpholin-2-ylmethoxy)phenyl)-3-(5-methylpyrazin-2-yl)urea,
ly2603618 IC-83,
n-(5-bromo-4-methyl-2-((2s)-2-morpholinylmethoxy)phenyl)-n'-(5-methyl-2-pyrazinyl)urea,
LY2603618 (IC-83),
Rabusertib [USAN:INN],
3-(5-Bromo-4-methyl-2-[(2s)-morpholin-2-ylmethoxy]phenyl)-1-(5-methylpyrazin-2-yl)urea,
3-{5-bromo-4-methyl-2-[(2S)-morpholin-2-ylmethoxy]phenyl}-1-(5-methylpyrazin-2-yl)urea,
N-[5-Bromo-4-methyl-2-[(2S)-2-morpholinylmethoxy)phenyl]-N'-(5-methyl-2-pyrazinyl)urea,
1-[5-bromo-4-methyl-2-[[(2S)-morpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea,
LY2603618(IC-83),
Rabusertib (USAN/INN),
MLS006011026,
SCHEMBL304747,
GTPL7960,
CHEMBL3039517,
DTXSID50238417,
EX-A426,
CHEBI:124917,
BCPP000178,
ABP000954,
s2626,
ZINC70466463,
AKOS027422721,
BCP9000873,
CS-0472,
DB11662,
RL05730,
SB19467,
Urea, N-(5-bromo-4-methyl-2-((2S)-2-morpholinylmethoxy)phenyl)-N'-(5-methyl-2- pyrazinyl)-,
LY2603618-IC-83,
NCGC00343768-01,
BC638812,
HY-14720,
SMR004702821,
FT-0772513,
LY2603618 - IC-83,
SW219621-1,
D10397,
W-5770,
LY2603618 (IC-83)/IC-83,
J-523102,
IC-83;LY 2603618;LY-2603618,
IC-83, LY 2603618, LY-2603618, 911222-45-2,
LY-2603618|||1-[5-Bromo-4-methyl-2-[[(2S)-morpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea,
Rabusertib [USAN],
D00NZL,
cc-579,
ACN-053690,
CID11955855,
A8638,
A11036,
C582547,